News

    First ARM2 patient included

    The study ARM2 of the TNBC-MERIT clinical trial was opened in September 2017 by recommendation of the DSMB. The first patient was enrolled in October 2017 in Germany. The patient will receive the on-demand manufactured individualized cancer vaccine at the beginning of next year. Read more

    MERIT at CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference

    The MERIT Project was successfully presented to the scientific community at the Third CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference in Mainz, Germany on September 6-9, 2017. Read more

    MERIT Annual Meeting 2017

    The consortium partners of the MERIT project came together in Uppsala, Sweden on September 12th to discuss the project status, preliminary data from the first patients and scientific advances that have been achieved within the last year. The meeting was kindly hosted by Consortium Partner Tobias Sjöblom from Uppsala University. Read more

    MERIT Annual Meeting 2016

    The Annual Meeting 2016 took place September 5th and 6th in Mainz, Germany. The consortium partners of the MERIT project got together and discussed the project status, the clinical trial, and scientific advances that have been achieved within the framework of the MERIT Project. The Meeting was a full success and the Consortium enjoyed to share their experiences and expertise. Read more

    MERIT consortium at CIMT 2016

    The MERIT consortium was presented at the 14th CIMT annual meeting. From all over the world experts came together in Mainz, Germany, to discuss “Mechanisms of efficacy in cancer immunotherapy”. Read more

    MERIT consortium at AACR 2016

    The MERIT project and consortium was presented with a poster and talk at the annual meeting of the American Association for Cancer Research (AACR) in 2016 in New Orleans, USA. The theme of the meeting was “Delivering cures through cancer science” and the latest, most exciting discoveries were presented in every area of cancer research. Read more

    MERIT consortium at the mRNA Health Conference 2015

    The MERIT consortium was presented at the 3rd International mRNA Health Conference in 2015. The conference was held in Berlin, Germany, and offered an opportunity to hear about the latest mRNA research and mRNA therapeutics. Read more

    MERIT Annual Meeting 2015

    The Annual Meeting 2015 took place on the 20th of October 2015 in Brussel, Belgium, and was kindly hosted by Consortium Partner Kris Thielemans and Jacques de Greve from the Vrije Universiteit Brussel. BioNTech presented the latest results of ongoing studies and an overall project overview and update was given. Read more

    MERIT consortium at the Young Academics Conference 2015

    The MERIT consortium was presented at the Young Academics Conference of the DKTK School of Oncology in Heidelberg, Germany. Read more